{"status":"ok","report":{"price_analysis":{"current":20.77,"change_1d":0.0,"change_7d":-3.2,"change_30d":-7.3,"high_30d":23.88,"low_30d":19.75,"position_in_range":25.0,"support":20.16,"resistance":23.47},"summary":"City Therapeutics, Inc. Common Stock(CTY)은 Healthcare 섹터 US 시장 종목입니다, 시가총액 10.45억. 현재가 $20.77, 전일 대비 +0.0%, 30일 -7.3%.","disclaimer":"본 리포트는 데이터 기반 자동 분석이며, 투자 판단은 투자자 본인의 책임입니다.","fundamentals":{"analysis":"시가총액 10.45억.","grade":"C","comment":"펀더멘탈 데이터 부족","per":null,"pbr":null,"roe":null,"eps":null,"revenue":null,"operating_income":null,"net_income":null,"market_cap":1045401435,"profit_margin":null,"roa":null,"operating_margin":null,"gross_margin":null,"debt_ratio":null,"total_assets":null,"total_equity":null,"total_debt":null,"eps_basis":null},"technical":{"analysis":"기술적 지표 데이터가 부족합니다.","trend":"횡보","grade":"C","comment":"횡보 추세","rsi_14":null,"macd":null,"macd_signal":null,"sma_20":null,"sma_60":null,"bb_upper":null,"bb_lower":null,"atr_14":null},"news":{"analysis":"최근 30일 관련 뉴스가 없습니다.","sentiment":"중립","key_topics":[]},"news_links":[],"supply_demand":{"analysis":"수급 데이터가 없습니다.","foreign_trend":"중립","institution_trend":"중립","comment":"데이터 부족"},"backtest":{"analysis":null,"best_strategy":null,"comment":null,"alpha_locked":true,"locked_message":"개별종목 투자판단(매수/매도·목표가)은 알파(PRO) 구독에서 제공됩니다."},"grades":{"valuation":{"grade":"C","percentile":null,"summary":"밸류에이션 데이터 부족","metrics":[]},"growth":{"grade":"C","percentile":null,"summary":"성장성 데이터 부족","metrics":[]},"profitability":{"grade":"C","percentile":null,"summary":"수익성 데이터 부족","metrics":[]},"momentum":{"grade":"D","percentile":37,"summary":"모멘텀 데이터 부족","metrics":[{"name":"30일 수익률","value":-7.3,"unit":"%","percentile":37,"direction":"higher_better"}]},"signal":{"grade":null,"percentile":null,"summary":null,"metrics":[],"alpha_locked":true,"locked_message":"개별종목 투자판단(매수/매도·목표가)은 알파(PRO) 구독에서 제공됩니다.","unlock_tier":"data"}},"investment_grade":{"valuation":{"grade":"C","reason":"밸류에이션 데이터 부족"},"growth":{"grade":"C","reason":"성장성 데이터 부족"},"profitability":{"grade":"C","reason":"수익성 데이터 부족"},"momentum":{"grade":"D","reason":"모멘텀 데이터 부족"},"signal_performance":{"grade":null,"reason":null,"alpha_locked":true}},"buffett_checklist":{"items":[{"metric":"ROA","value":null,"unit":"%","threshold":"≥ 10%","pass":false,"source":"버핏"},{"metric":"ROE","value":null,"unit":"%","threshold":"≥ 15%","pass":false,"source":"버핏, 린치"},{"metric":"ROIC","value":null,"unit":"%","threshold":"≥ 10%","pass":false,"source":"버핏, 그린블라트"},{"metric":"Debt/Equity","value":null,"unit":"","threshold":"≤ 0.5","pass":false,"source":"버핏, 그레이엄","label_kr":"D/E(유이자부채/자본총계)","definition":"유이자부채(단기+장기 차입금) ÷ 자본총계. 무이자부채는 제외한다.","comparable_across_markets":false},{"metric":"LT Debt/Equity","value":null,"unit":"","threshold":"≤ 0.5","pass":false,"source":"보조지표","label_kr":"장기차입금비율(장기차입금/자본총계)","definition":"유이자 장기부채 ÷ 자본총계. KR·US 정의가 동일하다.","comparable_across_markets":true},{"metric":"Gross Margin","value":null,"unit":"%","threshold":"≥ 40%","pass":false,"source":"버핏"},{"metric":"Oper Margin","value":null,"unit":"%","threshold":"≥ 20%","pass":false,"source":"버핏"},{"metric":"Profit Margin","value":null,"unit":"%","threshold":"≥ 15%","pass":false,"source":"버핏"}],"pass_count":0,"total_count":8,"overall_comment":"재무 데이터가 부족해 체크리스트를 측정하지 못했습니다."},"risk_factors":["특별한 경고 요인 없음"],"catalysts":["추가 분석 필요"],"market_condition":{"trend":"중립","summary":"시장 지표 데이터 부족"},"valuation_band":{"current_per":null,"current_pbr":null,"per_5y_high":null,"per_5y_low":null,"per_5y_avg":null,"per_percentile":null,"pbr_5y_high":null,"pbr_5y_low":null,"pbr_5y_avg":null,"pbr_percentile":null,"per_5y_median":null,"pbr_5y_median":null,"history":[],"fair_value_per":null,"fair_value_pbr":null,"timeline":[],"forward":{"per":null,"eps":null,"target_price":null,"source":null,"fair_value":null,"forward_at_avg":null},"fair_value_locked":true,"locked_message":"밸류에이션 밴드 기반 가치 추정은 데이터(DATA) 구독에서 제공됩니다. 밴드 위치(PER·PBR 백분위)는 계속 무료로 제공됩니다.","unlock_tier":"data","available":false},"peer_comparison":{"peers":[],"sector":"Healthcare","industry":"Biotechnology"},"earnings_forecast":{},"fwd_per_history":[],"fwd_per_history_meta":{},"trailing_per_history":[],"trailing_per_history_meta":{},"eps_revisions":{"available":false,"grade":null,"score":null,"rev_30d_pct":null,"rev_90d_pct":null,"direction":null,"up_count":0,"down_count":0,"latest_eps":null,"latest_date":null,"analyst_count":null,"history":[],"reason":"no_snapshots"},"dividend":{"dividend_yield":null,"has_dividend":false},"meta":{"generated_at":"2026-10-24T23:08:30.012993+00:00","sections":{"supply_demand":{"status":"unavailable_market","reason":"kr_only"},"prices":{"status":"available","as_of":"2026-10-23"},"chart_data":{"status":"available","as_of":"2026-10-23"},"technical":{"status":"unavailable_size","reason":"no_technical_14d"},"price_history":{"status":"available","as_of":"2026-10-23"},"portfolio":{"status":"available"},"fundamental":{"status":"unavailable_size","reason":"no_fundamental_3y"},"etf_profile":{"status":"unavailable_size","reason":"not_etf"}}},"financial_currency":{"current_held":false,"quote_currency":"USD","latest_currency":null,"latest_period":null,"foreign_observed":false},"fundamentals_history":[],"current_price":20.77,"change_pct":0.0,"backtest_top3":[],"signals":[],"insider_trades":[],"institutional_holders":[],"portfolio":null,"price_history":[{"date":"2026-10-16","close":22.4},{"date":"2026-10-19","close":21.46},{"date":"2026-10-20","close":20.83},{"date":"2026-10-21","close":20.43},{"date":"2026-10-22","close":20.77},{"date":"2026-10-23","close":20.77}],"chart_data":[{"date":"2026-10-16","open":23.0,"high":23.88,"low":20.5,"close":22.4,"volume":1406423},{"date":"2026-10-19","open":21.94,"high":22.0,"low":21.03,"close":21.46,"volume":302368},{"date":"2026-10-20","open":21.44,"high":21.5,"low":20.0,"close":20.83,"volume":633156},{"date":"2026-10-21","open":20.78,"high":21.69,"low":19.97,"close":20.43,"volume":283087},{"date":"2026-10-22","open":20.41,"high":20.88,"low":19.75,"close":20.77,"volume":127597},{"date":"2026-10-23","open":20.62,"high":21.14,"low":20.03,"close":20.77,"volume":343836}],"backtest_alpha_locked":true,"portfolio_locked":true,"portfolio_locked_message":"데답 모델포트폴리오는 유사투자자문업 신고 완료 후 오픈됩니다.","insider_data_locked":true,"insider_locked_message":"내부자 매매(Form 4)·기관 13F·스마트머니 등급은 데이터(DATA) 구독에서 제공됩니다.","insider_unlock_tier":"data"},"stock_name":"City Therapeutics, Inc. Common Stock","phase":"above-fold","symbol_resolved":true}